“While the start of the calendar year is often prime time for U.S. Food and Drug Administration (FDA) events and trial data to be released, the summer also heats up for drugmakers and biotech stocks. The next few months feature several major events for a number of biotechnology firms and their shareholders,” advises the author of today’s article. With that, he proceeds to highlight eight particular biotech stocks to watch with major catalysts in the next few months. For more, CLICK HERE.
With Major Catalysts This Summer, These 8 Biotech Stocks Could Heat Up
- by RobH